×
戻る Agenda
Session 3: Innovative Approaches and Quantitative Sciences in Drug Development
Session Chair(s)
Jee Eun Lee
Vice President
LG Chem , Korea, Republic of
Innovative drug development aims to improve not only time efficiency or cost effectiveness but also the quality of presentation of a drug product by maximizing its potential benefits that outweighs the risks. Quantitative data sciences including pharmacometrics have grown drastically due to their contribution to achieving such aims. Recent examples of innovative approaches in drug development will be presented and how quantitative sciences can be utilized in decision making and drug approval will be discussed.
Speaker(s)
The Need for Better Approaches in Oncology Drug Development
Geoffrey Kim
BeiGene, United States
Managing Director
Application Of Pharmacometrics In Drug Development: A Case Study
Jae Yeon Kim
Novartis, United States
Senior Director Early Development Oncology Pharmacometrics